Cargando…
Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model
Probiotics have been widely used to prevent primary Clostridioides difficile infection (pCDI); however, there are fewer studies on their therapeutic aspects for pCDI. In this study, high doses of Bifidobacterium breve YH68 were used alone or in combination with vancomycin (VAN) and metronidazole (MT...
Autores principales: | Yang, Jingpeng, Meng, Lingtong, Yang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045379/ https://www.ncbi.nlm.nih.gov/pubmed/35311540 http://dx.doi.org/10.1128/spectrum.00672-22 |
Ejemplares similares
-
Antibacterial Activity of Bifidobacterium breve Against Clostridioides difficile
por: Yang, Jingpeng, et al.
Publicado: (2019) -
Transcriptome Analysis of the Clostridioides difficile Response to Different Doses of Bifidobacterium breve
por: Yang, Jingpeng, et al.
Publicado: (2020) -
Effect of Bifidobacterium breve in Combination With Different Antibiotics on Clostridium difficile
por: Yang, Jingpeng, et al.
Publicado: (2018) -
Which is the Preferred Regimen for Non-Severe Clostridioides difficile Infection in Korea, Vancomycin or Metronidazole?
por: Kim, Jieun, et al.
Publicado: (2022) -
Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
por: Dubberke, Erik R, et al.
Publicado: (2020)